Quality of Life of the Patient and the Burden of the Caregiver in Progressive Supranuclear Palsy
Recruiting
Observational Study
Progressive Supranuclear Palsy
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 200 (estimated)
- Sponsor
- Assistance Publique Hopitaux De Marseille · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Progressive supranuclear palsy (PSP) is a rare neurodegenerative disease from the parkinsonian syndrome group.
PSP is characterised by the association of a non-doparesponsive parkinsonian syndrome with axial signs. The latter predominantly manifest as a psycho-motor slowness, an apathy and frontal executive deficits. Swallowing impairments may additionally provoke life-threatening situations. Tod…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria (patients)
Female or male, age ≥ 40 years at the time of onset of symptoms
* diagnosis of possible or probable PSP according to the criteria of Litvan (1996b)
* agreeing to participate in the study
* subject with no severe cognitive impairment (MMS\> 20/30)
* subject who does no…
Contacts